Stock listing

Conavi Medical Corp.

Selected listing: A40RA7 · LS · EUR · DE

Conavi Medical Corp. (Lang & Schwarz: A40RA7), Health Technology. Latest release Sep 17, 2026: Conavi Medical Announces Peer-Reviewed Case Report Highlighting…

A40RA7:LSEURDEUpdated October 2, 2026

Ticker: Lang & Schwarz: A40RA7
Asset type: Stock
Sector: Health Technology
Industry: Medical Specialties
Exchange: Lang & Schwarz
Currency: EUR

About Conavi Medical Corp.

The company focuses on developing innovative medical technologies to improve patient outcomes. Conavi Medical is committed to advancing healthcare solutions through its proprietary products and research initiatives.

Latest news from Conavi Medical Corp.

Conavi Medical Announces Peer-Reviewed Case Report Highlighting Clinical Utility of Hybrid IVUS-OCT Imaging, and Provides Update on Management Team

September 17, 2026

Conavi Medical Announces Media and Digital Marketing Agreements

September 4, 2026

Conavi Medical Reports Fiscal Third Quarter 2026 Results and Operational Highlights

August 27, 2026

Conavi Medical Corp. Announces Closing of $10M Public Offering

August 12, 2026

Conavi Medical Announces JSCAI Publication Demonstrating the Clinical Utility of Hybrid IVUS OCT Imaging

July 8, 2026

All Conavi Medical Corp. news →

Research Conavi Medical Corp.

Conavi Medical Corp. company profile

View the public company page for Conavi Medical Corp. on 6ix.

Conavi Medical Corp. news

Read company news and market updates connected to Conavi Medical Corp..

Conavi Medical Corp. investor events

Find investor webinars, events, and replay context for Conavi Medical Corp..